X
Total 422235 Results
| Label | Description | ILX | Version | Created CID | Modified Time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performed Station AE Title | AE title of the modality on which the Performed Procedure Step was performed. | ILX:0108702 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performed Station Class Code Sequence | Class of the equipment that created the General Purpose Performed Procedure Step. Zero or one Item may be included in this sequence. | ILX:0108703 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performed Station Geographic Location Code Sequence | Geographic location of the equipment that created General Purpose Performed Procedure Step. Zero or one Item may be included in this sequence. | ILX:0108704 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performed Station Name | An institution defined name for the modality on which the Performed Procedure Step was performed. | ILX:0108705 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performed Station Name Code Sequence | Name within the enterprise of the equipment that created the General Purpose Performed Procedure Step. This name may be the same as the AE Title, but does not have to be. Zero or one Item may be included in this sequence. | ILX:0108706 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performed Workitem Code Sequence | A sequence that conveys the (single) type of procedure performed. Only a single Item shall be permitted in this sequence. | ILX:0108707 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performing Physician Identification Sequence | Identification of the physician(s) administering the Series. One or more items shall be included in this sequence. If more than one Item, the number and order shall correspond to the value of Performing Physicians Name (0008,1050), if present. | ILX:0108708 | 4 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Performing Physician's Name | Name of the physician(s) administering the Series. | ILX:0108709 | 6 | FDI Lab - SciCrunch.org | 08/28/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | troy sincomb |
| Perfusion System | 4,8 and often 16-channel perfusion systems designed for single channel and whole-cell patch preparations consist of pools (often in syringes) that fill small tubing (PE160 is typical) and contain a switch (electronic or mechanical) that turns on a particular channel. These are typically used in drug delivery. | ILX:0108710 | 3 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Perfusion-weighted MRI 2D image | ILX:0108711 | 3 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex | |
| Pergolide | A long-acting dopamine agonist which is effective in the treatment of Parkinson's disease and hyperprolactinemia. It has also been observed to have antihypertensive effects. (PubChem) Pharmacology: Pergolide is an ergot derivative dopamine receptor agonist at both D1 and D2 receptor sites. Pergolide is 10 to 1,000 times more potent than bromocriptine on a milligram per milligram basis in various in vitro and in vivo test systems. Pergolide mesylate inhibits the secretion of prolactin in humans; it causes a transient rise in serum concentrations of growth hormone and a decrease in serum concentrations of luteinizing hormone. In Parkinsons disease, pergolide mesylate is believed to exert its therapeutic effect by directly stimulating postsynaptic dopamine receptors in the nigrostriatal system. Mechanism of action: Pergolide is a potent dopamine receptor agonist. It directly stimulates post-synaptic dopamine receptors at both D1 and D2 receptor sites in the nigrostriatal system. Drug type: Approved. Small Molecule. Drug category: Antidyskinetics. Antiparkinson Agents. Central Nervous System Agents. Dopamine Agonists. Neuroprotective Agents | ILX:0108712 | 4 | FDI Lab - SciCrunch.org | 08/24/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | troy sincomb |
| Perhexiline | 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. (PubChem) Pharmacology: Used in the treatment of unresponsive or refractory angina. Perhexiline increases glucose metabolism at the expense of free-fatty-acid metabolism, enhancing oxygen efficiency during myocardial ischaemia. Perhexiline also potentiates platelet responsiveness to nitric oxide both in patients with angina and patients with acute coronary syndrome. The predominant mechanism of this particular perhexiline effect is an increase in platelet cGMP responsiveness. Perhexiline also may reduce the potential for nitric oxide clearance by neutrophil-derived oxygen. Perhexiline relieves symptoms of angina, improves exercise tolerance, and increases the workload needed to induce ischaemia when used as monotherapy. The primary therapeutic roles for perhexiline are as short-term therapy (less than 3 months duration) in patients with severe ischaemia awaiting coronary revascularisation or long-term therapy in patients with ischaemic symptoms refractory to other therapeutic measures. Mechanism of action: Perhexiline binds to the mitochondrial enzyme carnitine palmitoyltransferase (CPT)-1 and CPT-2. It acts by shifting myocardial substrate utilisation from long chain fatty acids to carbohydrates through inhibition of CPT-1 and, to a lesser extent, CPT-2, resulting in increased glucose and lactate utilization. Drug type: Approved. Small Molecule. Drug category: Calcium Channel Blockers. Cardiovascular Agents. Vasodilator Agents | ILX:0108713 | 3 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Peri Cellular Basket | Ramification of basket cell axon surrounding cell bodies, forming the characteristic peri-cellular baskets from which the cell class derives its name. | ILX:0108714 | 9 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Periamygdaloid area | 'Periamygdaloid area' is a cerebral hemisphere gray matter. It is part of the parahippocampal gyrus. | ILX:0108715 | 10 | FDI Lab - SciCrunch.org | 01/17/2023 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Periamygdaloid cortex | Is located ventral to the basal nucleus and has three subdivisions: the periamygdaloid cortex, the medial division, and the sulcal division. | ILX:0108716 | 6 | FDI Lab - SciCrunch.org | 01/17/2023 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Periaqueductal gray of midbrain | Periaqueductal gray (PAG; also called the 'central gray') is the gray matter located around the cerebral aqueduct within the midbrain. It plays a role in the descending modulation of pain and in defensive behaviour. The ascending pain and temperature fibers of the spinothalamic tract also send information to the PAG via the spinomesencephalic tract. The spinomesencephalic tract is so-named because the fibers originate in the spine and terminate in the mesencephalon, another name for the midbrain, the part of the brain in which the PAG resides. [WP,unvetted]. | ILX:0108717 | 12 | FDI Lab - SciCrunch.org | 01/17/2023 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | Maryann Martone |
| Periaqueductal gray of ABA 2009 | ILX:0108718 | 3 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex | |
| Pericalcarine cortex | Component of the parietal lobe. The rostral boundary of the pericalcarine cortex was the first appearance of the calcarine sulcus whereas the caudal boundary was the most posterior coronal slice where the calcarine sulcus was visualized. The medial and lateral boundaries were the medial portion of the temporal and occipital cortices and the inferomedial end of the calcarine sulcus respectively (Christine Fennema-Notestine). | ILX:0108719 | 7 | FDI Lab - SciCrunch.org | 01/17/2023 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Pericentral nucleus of inferior colliculus | 'Pericentral nucleus of inferior colliculus' is a nucleus of midbrain tectum. It is part of the inferior colliculus. | ILX:0108720 | 11 | FDI Lab - SciCrunch.org | 01/17/2023 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
| Pericyte | slender, contractile, mesenchymal-like cell found in close association with capillary walls. They are relatively undifferentiated and may become fibroblasts, macrophages, or smooth muscle cells. (From OBO Cell Type Ontology). | ILX:0108721 | 3 | FDI Lab - SciCrunch.org | 06/18/2018 | FDI Lab - SciCrunch.org | term | 12/09/2016 | 0 | NeuroLex | NeuroLex |
About
The SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
Contact Us
FAIR Data Informatics Lab
University of California, San Diego
9500 Gilman Drive, Mail Code 0608
La Jolla, CA 92093-0608
United States
info 
scicrunch.org
scicrunch.org
X